The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Tumor Self-Seeding by Circulating Cancer Cells
Open accessAbstract
Cancer cells that leave the primary tumor can seed metastases in distant organs, and it is thought that this is a unidirectional process. Here we show that circulating tumor cells (CTCs) can also colonize their tumors of origin, in a process that we call "tumor self-seeding." Self-seeding of breast cancer, colon cancer, and melanoma tumors in mice is preferentially mediated by aggressive CTCs, including those with bone, lung, or brain-metastatic tropism. We find that the tumor-derived cytokines IL-6 and IL-8 act as CTC attractants whereas MMP1/collagenase-1 and the actin cytoskeleton component fascin-1 are mediators of CTC infiltration into mammary tumors. We show that self-seeding can accelerate tumor growth, angiogenesis, and stromal recruitment through seed-derived factors including the chemokine CXCL1. Tumor self-seeding could explain the relationships between anaplasia, tumor size, vascularity and prognosis, and local recurrence seeded by disseminated cells following ostensibly complete tumor excision.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, tumor self-seeding leads to enhanced angiogenesis, tumor growth, stromal recruitment through seed-derived factors including the chemokine CXCL1, anaplasia, tumor size, and vascularity.”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [147]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mechanistically, tumors secrete IL-6 and IL-8 cytokines to attract CTC”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [147]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In this way, aggressive CTCs preferentially mediate self-seeding of breast, melanoma, and colon cancers in mice, including those with bone, brain, or lung -metastatic tropism.”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [147]
The cited source says what the claim attributes to it.
In the citing paper
“Even more interesting is that, in contrast to the traditional view that tumor cell metastases occur unidirectional, the reverse process is also possible through CTC-mediated “self-seeding”.”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [147]
The cited source says what the claim attributes to it.
In the citing paper
“while CTC infiltration into mammary tumors is mediated by MMP1/collagenase-1 and the actin cytoskeleton component fascin-1.”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [147]
The cited source says what the claim attributes to it.
In the citing paper
“Finally, there is the prognosis for local recurrence by seeding of disseminated cells after apparently complete tumor ablation [147, 148].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [147]
In the citing paper
“CXCL1 emerged among a set of genes whose expression is associated with lung relapse in breast tumors, including tumors that had not been exposed to prior chemotherapy (Minn et al., 2007; Minn et al., 2005), and as a gene that increases the aggressiveness of circulating breast tumor cells (Kim et al., 2009).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Kim et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Self-citationMetastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,716
Self-citationA multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
Self-citationParadoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1782 · Cited by 2,299
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,000
Method validation of circulating tumour cell enumeration at low cell counts
Cummings, J., Morris, K. L., Zhou, C., Sloane, R. A. S., Lancashire, M., Morris, D., Bramley, S., Krebs, M., Khoja, L., & Dive, C. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-415 · Cited by 19
Huang, Y., Chen, J. L., Huang, C., Kuo, S., Jaw, F., Tseng, Y., Ko, W., & Chang, Y. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0784-3 · Cited by 19
Bianchini, D., Lorente, D., Rescigno, P., Zafeiriou, Z., Psychopaida, E., O’Sullivan, H., Alaras, M., Kolinsky, M. P., Sumanasuriya, S., Fontes, M. S., et al. (2017) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2017.04.013 · Cited by 19
Zhang, Y., Zheng, H., Zhan, Y., Long, M., Liu, S., Lu, J., Zang, H., & Fan, S. (2018) · Europe PMC (PubMed Central) · Cited by 19
Benjamin, D. C., Kang, J. H., Hamza, B. M., King, E. M., Lamar, J. M., Manalis, S. R., & Hynes, R. O. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0212 · Cited by 21
Circulating Tumor Cells: A Window into Tumor Development and Therapeutic Effectiveness
Cáceres, G., Puskas, J., & Magliocco, A. M. (2015) · Cancer Control · doi:10.1177/107327481502200207 · Cited by 18
Somatic copy number aberrations in metastatic patients: The promise of liquid biopsies
Baldacchino, S., & Grech, G. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.014 · Cited by 18
Li, X., Sun, H., Liu, Q., Liu, Y., Hou, Y., & Jin, W. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02415-8 · Cited by 18
The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer
Luo, K., Wang, X., Zhang, X., Liu, Z., Huang, S., & Li, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933645 · Cited by 18
Self-citationHuang, Z., Wen, J., Wang, Y., Han, S., Li, Z., Hu, X., Zhu, D., Wang, Z., Liang, J., Liang, H., et al. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0928-z · Cited by 18
Aptamer‐Modified Nanohydrogel Microarrays for Bioselective Cancer Cell Immobilization
Lamberger, Z., Bargel, H., & Humeník, M. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202207270 · Cited by 19
The tumor-immune ecosystem in shaping metastasis
Gao, Y., Rosen, J. M., & Zhang, X. H.-F. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00132.2022 · Cited by 18
Self-citationKang, Q., He, L., Zhang, Y., Zhong, Z., & Tan, W. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155684 · Cited by 19
Modeling the connection between primary and metastatic tumors
de Diego, D. M., Calvo, G. F., & Pérez‐García, V. M. (2012) · Journal of Mathematical Biology · doi:10.1007/s00285-012-0565-2 · Cited by 18
Isolation and elution of Hep3B circulating tumor cells using a dual-functional herringbone chip
Xue, P., Ye, K., Gao, J., Wu, Y., Guo, J., Hui, K. M., & Kang, Y. (2013) · Microfluidics and Nanofluidics · doi:10.1007/s10404-013-1250-5 · Cited by 18
Allen, J. E., Patel, A. S., Prabhu, V. V., Dicker, D. T., Sheehan, J. M., Glantz, M., & El‐Deiry, W. S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2660 · Cited by 18
Circulating tumor cells and coagulation—Minireview
Bystrický, B., Reuben, J. M., & Mego, M. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.04.003 · Cited by 19
Redmond, H. P., Neary, P., Jinih, M., O’Connell, E., Foley, N. M., Pfirrmann, R. W., Wang, J. H., & O’Leary, D. P. (2018) · BMC Cancer · doi:10.1186/s12885-018-4641-x · Cited by 18
Wang, X., Ma, K., Yang, Z., Cui, J., He, H., Hoffman, A. R., Hu, J., & Li, W. (2017) · Journal of Cancer · doi:10.7150/jca.18032 · Cited by 18
Patel, D. N., Jha, S., Howard, L. E., Amling, C. L., Aronson, W. J., Cooperberg, M. R., Kane, C. J., Terris, M. K., Chapin, B. F., & Freedland, S. J. (2018) · International Journal of Urology · doi:10.1111/iju.13806 · Cited by 18
Approaches to isolation and molecular characterization of disseminated tumor cells
Magbanua, M. J. M., Das, R., Polavarapu, P., & Park, J. W. (2015) · Oncotarget · doi:10.18632/oncotarget.5568 · Cited by 18
Teixeira, A. F., Wang, Y., Iaria, J., ten Dijke, P., & Zhu, H. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70055 · Cited by 18
Huang, J., Hu, X., Chen, Z., Ouyang, F., Li, J., Hu, Y., Zhao, Y., Wang, J., Yao, F., Jing, J., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03089-5 · Cited by 18
Beauval, J., Loriot, Y., Hennequin, C., Rozet, F., Barthélémy, P., Borchiellini, D., Constans, F. S., Gross, E., Maillet, D., Pasticier, G., et al. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.12.012 · Cited by 17
Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer
Huang, Z., Tan, Q., Qin, Q., Mo, Q., & Wei, C. (2021) · Cancer Management and Research · doi:10.2147/cmar.s280470 · Cited by 17
Law, V., Chen, Z., Vena, F., Smalley, I., Macaulay, R. J. B., Evernden, B. R., Tran, N., Piña, Y., Puskas, J., Cáceres, G., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac054 · Cited by 18
Haque, N., Raza, A., McGoey, R. R., Boulmay, B. C., Diethelm, L., & Kantrow, S. P. (2012) · Southern Medical Journal · doi:10.1097/smj.0b013e3182601198 · Cited by 17
A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential
Batra, J. S., Girdhani, S., & Hlatky, L. (2014) · Journal of Biomarkers · doi:10.1155/2014/321680 · Cited by 17
Fa, K.-N., Yang, C., Chen, P.-C., Lee, Y.-Y., Chyau, C.-C., & Hu, M. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.01.004 · Cited by 17
Extracorporeal Photo-Immunotherapy for Circulating Tumor Cells
Kim, G., & Gaitas, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127219 · Cited by 17
Metastasis and the evolution of dispersal
Tissot, T., Massol, F., Újvári, B., Alix‐Panabières, C., Loeuille, N., & Frédéric Thomas, A. (2019) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2019.2186 · Cited by 18
Hahnfeldt, P., Hlatky, L., & Klement, G. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3807 · Cited by 16
Yu, S., Cheng, L., Tian, D., Li, Z., Yao, F., Luo, Y., Liu, Y., Zhu, Z., Zheng, M., & Jing, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.729524 · Cited by 16
Transcriptomic changes during stage progression of mycosis fungoides
Xiao, M. Z. X., Hennessey, D., Iyer, A., O’Keefe, S. J., Zhang, F., Sivanand, A., & Gniadecki, R. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20760 · Cited by 16
Ferro, M., Crocetto, F., Lucarelli, G. T., Lievore, E., & Barone, B. (2022) · Diagnostics · doi:10.3390/diagnostics12081981 · Cited by 16
Villa, A. M., Mitri, Z. D., Vincenti, S., Crippa, E., Castiglioni, L., Gelosa, P., Rebecchi, M., Tosi, D., Brunialti, E., Oevermann, A., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116201 · Cited by 16
Genetic analysis of circulating tumor cells in pancreatic cancer patients: A pilot study
Görner, K., Bachmann, J., Holzhauer, C., Kirchner, R., Raba, K., Fischer, J., Martignoni, M. E., Schiemann, M., & Alunni‐Fabbroni, M. (2015) · Genomics · doi:10.1016/j.ygeno.2015.02.003 · Cited by 16
Gene profiling analysis for patients with oral verrucous carcinoma and oral squamous cell carcinoma.
Wang, Y., Tian, X., Liu, O., Fang, X., Quan, H., Xie, S., Gao, S., & Tang, Z. (2014) · Europe PMC (PubMed Central) · Cited by 16
Growth and Characterization of Irradiated Organoids from Mammary Glands
Hacker, B. C., Gomez, J. D., Batista, C. A. S., & Rafat, M. (2019) · Journal of Visualized Experiments · doi:10.3791/59293 · Cited by 16
Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
Sassu, C. M., Palaia, I., Boccia, S. M., Caruso, G., Perniola, G., Tomao, F., Donato, V. D., Musella, A., & Muzii, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413650 · Cited by 16
Biologie du processus métastatique
Bidard, F., & Poupon, M. (2012) · médecine/sciences · doi:10.1051/medsci/2012281022 · Cited by 15
Takada, T., Tsutsumi, S., Takahashi, R., Ohsone, K., Tatsuki, H., Suto, T., Kato, T., Fujii, T., Yokobori, T., & Kuwano, H. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24255 · Cited by 15
Sami, E., Bogan, D. R., Molinolo, A., Koziol, J., & ElShamy, W. M. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00311-x · Cited by 15
Ren, S., Li, H., Xu, X., Zhao, H., He, W., Zhang, L., & Cheng, Z. (2022) · Biomaterials Science · doi:10.1039/d2bm01727j · Cited by 15
Sun, B., Ji, W., Wang, W., Chen, L., Ma, J., Tang, E., Lin, M., & Zhang, X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1265866 · Cited by 15
Self-citationWishart, G., Templeman, A., Hendry, F., Miller, K. S., & Jimenez, A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46010050 · Cited by 15
Lee, J., Han, Y., Kim, S., Jo, H., Wang, W., Cho, U., Kim, S. I., Kim, B., & Song, Y. S. (2024) · Cancer Science · doi:10.1111/cas.16064 · Cited by 15
Programming tumor evolution with selection gene drives to proactively combat drug resistance
Leighow, S. M., Reynolds, J., Sokirniy, I., Yao, S., Yang, Z., Inam, H., Wodarz, D., Archetti, M., & Pritchard, J. R. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02271-7 · Cited by 15
Zoledronic Acid in the Treatment of Early-Stage Breast Cancer: Is There a Final Verdict?
Gnant, M. (2011) · Current Oncology Reports · doi:10.1007/s11912-011-0209-5 · Cited by 15
Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates
Aft, R., Perez, J.-R., Raje, N. S., Hirsh, V., & Fred Saad, C. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.05.009 · Cited by 15
Ariyasu, S., Hanaya, K., Watanabe, E., Suzuki, T., Horie, K., Hayase, M., Abe, R., & Aoki, S. (2012) · Langmuir · doi:10.1021/la302393p · Cited by 15
Recent insights into the development of nanotechnology to detect circulating tumor cells
Viswanath, B., & Kim, S. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.05.026 · Cited by 15
VCA nanobodies target N-WASp to reduce invadopodium formation and functioning
Hebbrecht, T., Audenhove, I. V., Zwaenepoel, O., Verhelle, A., & Gettemans, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185076 · Cited by 15
Disseminated Tumor Cells Predict Efficacy of Regional Nodal Irradiation in Early Stage Breast Cancer
Mignot, F., Loirat, D., Dureau, S., Bataillon, G., Caly, M., Vincent‐Salomon, A., Berger, F., Fourquet, A., Pierga, J., Kirova, Y., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.09.033 · Cited by 15
Treatment of the primary tumor in metastatic prostate cancer
Yuan, Y., Kishan, A. U., & Nickols, N. G. (2018) · World Journal of Urology · doi:10.1007/s00345-018-2552-8 · Cited by 15
The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis
Cheng, X., Ye, S., & Bai, P. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02265-8 · Cited by 15
Pan, Y., Li, D., Yang, J., Wang, N., Xiao, E., Tao, L., Ding, X., Sun, P., & Li, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.757307 · Cited by 15
Li, K., Luo, S., Guan, S., Situ, B., Wu, Y. S., Ou, Z., Tao, M., Zheng, L., & Cai, Z. (2022) · Talanta · doi:10.1016/j.talanta.2022.123531 · Cited by 15
Mohr, C. F., Christine, G., Bros, M., Reske‐Kunz, A. B., Biesinger, B., & Thoma‐Kress, A. K. (2015) · Virology · doi:10.1016/j.virol.2015.08.025 · Cited by 15
Reddi, A. H., Powers, M. A., & Dellavalle, R. P. (2014) · Experimental Dermatology · doi:10.1111/exd.12349 · Cited by 15
The cancer stem cell: Cell type or cell state?
Donnenberg, A. D., Hicks, J. B., Wigler, M. H., & Donnenberg, V. S. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22208 · Cited by 15
Kodama, H., Koie, T., Oikawa, M., Narita, T., Tanaka, T. D., Noro, D., Iwamura, H., Tobisawa, Y., Yoneyama, T., Hashimoto, Y., et al. (2020) · International Urology and Nephrology · doi:10.1007/s11255-019-02339-3 · Cited by 15
Gao, S., Chen, S., Liu, Y., Mao, H., & Lu, Q. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00577 · Cited by 14
Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and Therapy
Yu, Z., Song, M. L., Chouchane, L., & Ma, X. (2021) · Cancers · doi:10.3390/cancers13133276 · Cited by 14
A high-cholesterol diet promotes the intravasation of breast tumor cells through an LDL–LDLR axis
Magalhães, A., Cesário, V., Coutinho, D., Matias, I., Domingues, G., Pinheiro, C., Serafim, T. L., & Dias, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-59845-3 · Cited by 14
Ultrashort courses of adjuvant breast radiotherapy
Khan, A. J., Dale, R., Arthur, D. W., Haffty, B. G., Todor, D. A., & Vicini, F. A. (2011) · Cancer · doi:10.1002/cncr.26457 · Cited by 14
Methods for detection of circulating cells in non-small cell lung cancer
Han, Y. (2014) · Frontiers in bioscience · doi:10.2741/4255 · Cited by 14
Kim, K. N., Qureshi, M. M., Huang, D., Ko, N. Y., Cassidy, M. R., Oshry, L. J., & Hirsch, A. E. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2019.12.010 · Cited by 14
Marked epithelial to mesenchymal transition in surgical margins of oral cancer‑an in�vitro study
Lazarević, M. M., Marković, M. M., Jelovac, D. B., Milenković, S. M., Tepavčević, Z., Baldan, F., Subotički, T., Toljić, B., Trišić, D. D., Dragović, M., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11494 · Cited by 14
Chemokines in bone-metastatic breast cancer: Therapeutic opportunities
Wang, Y., Ren, S., Wang, Z., Wang, Z., Zhu, N., Cai, D., Ye, Z., & Ruan, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106815 · Cited by 15
Active Transport in Complex Environments
Martínez-Calvo, A., Trenado-Yuste, C., & Datta, S. S. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781839169465-00151 · Cited by 14
Sobhanan, J., Takano, Y., Sugino, S., Hirata, E., Yamamura, S., & Biju, V. (2022) · NPG Asia Materials · doi:10.1038/s41427-021-00353-5 · Cited by 14
Stem cells and colon cancer: The questionable cancer stem cell hypothesis
Gespach, C. P. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.08.014 · Cited by 14
Metastatic breast cancer: mechanisms and opportunities for cytology
Martins, D. F., de Beça, F. F., & Schmitt, F. C. (2014) · Cytopathology · doi:10.1111/cyt.12158 · Cited by 14
The metastatic cycle: metastatic niches and cancer cell dissemination
Géraud, C., Reiners-Koch, P.-S., Damm, F., Schledzewski, K., & Goerdt, S. (2014) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12451 · Cited by 14
Circulating tumor cells in breast cancer patients
Bystrický, B., & Mego, M. (2015) · Neoplasma · doi:10.4149/neo_2016_003 · Cited by 14
Vakiani, E., Shah, R. H., Berger, M. F., Makohon-Moore, A. P., Reiter, J. G., Ostrovnaya, I., Attiyeh, M. A., Cercek, A., Shia, J., Iacobuzio–Donahue, C. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17200 · Cited by 14
Giraud, J., Bouriez, D., Seeneevassen, L., Rousseau, B., Sifré, E., Giese, A., Mégraud, F., Lehours, P., Dubus, P. R., Gronnier, C., et al. (2019) · Cancers · doi:10.3390/cancers11040560 · Cited by 14
Reinecke, J. B., Garcia, L. J., Saraf, A. J., Hinckley, J., Gross, A. C., Pommellet, H. L., Gutpell, K. M., Cam, M., Cannon, M. V., Gust, M. J., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3360 · Cited by 13
Evaluating the relevance of surgical margins. Part one: The problems with current methodology
Bray, J., Eward, W. C., & Breen, M. (2022) · Veterinary and Comparative Oncology · doi:10.1111/vco.12865 · Cited by 13
Duran, C. L., Karagiannis, G. S., Chen, X., Sharma, V. P., Entenberg, D. R., Condeelis, J. S., & Oktay, M. H. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01628-1 · Cited by 13
Hao, Y.-J., Chang, L.-W., Yang, C., Lo, L., Lin, C., Jian, Y.-W., Jiang, J., & Tseng, F. (2023) · Translational research · doi:10.1016/j.trsl.2023.07.011 · Cited by 13
Serio, R. N., Scheben, A., Lu, B., Gargiulo, D. V., Patruno, L., Buckholtz, C. L., Chaffee, R. J., Jibilian, M. C., Persaud, S. G., Staklinski, S. J., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1332 · Cited by 14
Modeling NSCLC Progression: Recent Advances and Opportunities Available
Suleiman, A. A., Nogová, L., & Fuhr, U. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9461-y · Cited by 13
Comen, E. A., Morris, P. G., & Norton, L. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9267-z · Cited by 13
Self-citationSmolková, B., Mego, M., Kajabová, V. H., Čierna, Z., Danihel, Ľ., Sedláčková, T., Minárik, G., Zmetakova, I., Krivulcik, T., Gronesova, P., et al. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.03.004 · Cited by 13
Local Treatment of Metastatic Prostate Cancer: What is the Evidence So Far?
Almeida, P. L., & Pereira, B. J. (2018) · Prostate Cancer · doi:10.1155/2018/2654572 · Cited by 13
Ju, T., Wang, S.-W., Wang, J.-J., Yang, F., Song, Z.-X., Xu, H., Chen, Y., Zhang, J.-R., & Wang, Z.-B. (2020) · Analytical Methods · doi:10.1039/d0ay01730b · Cited by 10
Hilfenhaus, G., Mompeón, A., Freshman, J., Prajapati, D. P., Hernandez, G. E., Freitas, V. M., Ma, F., Langenbacher, A. D., Mirkov, S., Song, D., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3911 · Cited by 13
FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration
Li, S., Huang, X., Wang, M.-Y., Chen, D., Li, M., Zhu, Y.-Y., Yu, Y., Zheng, L., Qi, B., & Liu, J.-Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653005 · Cited by 14
Effects of Propofol Versus Sevoflurane on Postoperative Breast Cancer Prognosis: A Narrative Review
Fang, P., Zhou, J., Xia, Z., Lu, Y., & Liu, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.793093 · Cited by 13
HMMR promotes peritoneal implantation of gastric cancer by increasing cell–cell interactions
Yang, M., Chen, B., Kong, L., Chen, X., Ouyang, Y., Bai, J., Yu, D., Zhang, H., Li, X., & Zhang, D. (2022) · Discover Oncology · doi:10.1007/s12672-022-00543-9 · Cited by 13
Novel Roles of Nanog in Cancer Cells and Their Extracellular Vesicles
Saito, M. (2022) · Cells · doi:10.3390/cells11233881 · Cited by 14
When Prostate Cancer Circulates in the Bloodstream
Vlaeminck‐Guillem, V. (2015) · Diagnostics · doi:10.3390/diagnostics5040428 · Cited by 13
Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Condorelli, F., Stec‐Martyna, E., Zaborowska, J., Felli, L., Gnemmi, I., Ponassi, M., & Rosano, C. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796150522 · Cited by 13
Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer
Kacerovsky-Strobl, S., Wimmer, K., Exner, R., Devyatko, Y., Bolliger, M. J., Fitzal, F., & Gnant, M. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0535-z · Cited by 13
Organoids as Complex In Vitro Models for Studying Radiation-Induced Cell Recruitment
Hacker, B. C., & Rafat, M. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00625-0 · Cited by 15
Bioengineering Embryonic Stem Cell Microenvironments for the Study of Breast Cancer
Raof, N. A., Mooney, B., & Xie, Y. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12117662 · Cited by 13
Li, S., Guan, Q., Zhao, D., Guang-jun, P., Su, H., Du, L.-N., He, J., & Liu, Z.-C. (2016) · Medical Science Monitor · doi:10.12659/msm.898335 · Cited by 13
Fujimura, T., Kakizaki, A., Sato, Y., Tanita, K., Furudate, S., & Aiba, S. (2017) · Anticancer Research · doi:10.21873/anticanres.11639 · Cited by 13
Metadata
- Authors
- Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Massagué, Joan
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 139
- Issue
- 7
- Pages
- 1315-1326
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC2810531
- OpenAlex
- W2152393981
- Cited by
- 1,335
- References
- 57
- Citations by year
- 2026: 16 · 2025: 44 · 2024: 61 · 2023: 90 · 2022: 89 · 2021: 88 · 2020: 96 · 2019: 87 · 2018: 68 · 2017: 82 · 2016: 91 · 2015: 96 · 2014: 102 · 2013: 82 · 2012: 98
- FWCI
- 40.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Defense
- Howard Hughes Medical Institute
- National Institutes of Health
- National Cancer Institute (P01CA094060, CA94060, P30CA008748)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- circulating tumor cells, breast cancer, colon cancer, melanoma, interleukin-6, interleukin-8, MMP-1, fascin, CXCL1, tumor angiogenesis, tumor growth, local recurrence, metastatic tropism, actin cytoskeleton
- MeSH terms
- Animals, Breast Neoplasms, Humans, Melanoma, Mice, Inbred BALB C, Neoplastic Cells, Circulating, Neoplasm Proteins, Neoplasm Recurrence, Local, Neoplasms, Prognosis, Skin Neoplasms, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
